Low Expression of ELOVL6 May Be Involved in Fat Loss in White Adipose Tissue of Cancer-associated Cachexia

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Specialties Biochemistry
Endocrinology

Date 2024 May 17

PMID 38760797

Authors

Chenyang Jin

Shuangjie Wang

Xiangyu Sui

Qingyang Meng

Guohao Wu

Affiliations

Soon will be listed here.

Abstract

Background: Cancer-associated cachexia (CAC) arises from malignant tumors and leads to a debilitating wasting syndrome. In the pathophysiology of CAC, the depletion of fat plays an important role. The mechanisms of CAC-induced fat loss include the enhancement of lipolysis, inhibition of lipogenesis, and browning of white adipose tissue (WAT). However, few lipid-metabolic enzymes have been reported to be involved in CAC. This study hypothesized that ELOVL6, a critical enzyme for the elongation of fatty acids, may be involved in fat loss in CAC.

Methods: Transcriptome sequencing technology was used to identify CAC-related genes in the WAT of a CAC rodent model. Then, the expression level of ELOVL6 and the fatty acid composition were analyzed in a large clinical sample. Elovl6 was knocked down by siRNA in 3T3-L1 mouse preadipocytes to compare with wild-type 3T3-L1 cells treated with tumor cell conditioned medium.

Results: In the WAT of patients with CAC, a significant decrease in the expression of ELOVL6 was found, which was linearly correlated with the extent of body mass reduction. Gas chromatographic analysis revealed an increase in palmitic acid (C16:0) and a decrease in linoleic acid (C18:2n-6) in these tissue samples. After treatment with tumor cell-conditioned medium, 3T3-L1 mouse preadipocytes showed a decrease in Elovl6 expression, and Elovl6-knockdown cells exhibited a reduction in preadipocyte differentiation and lipogenesis. Similarly, the knockdown of Elovl6 in 3T3-L1 cells resulted in a significant increase in palmitic acid (C16:0) and a marked decrease in oleic acid (C18:1n-9) content.

Conclusion: Overall, the expression of ELOVL6 was decreased in the WAT of CAC patients. Decreased expression of ELOVL6 might induce fat loss in CAC patients by potentially altering the fatty acid composition of adipocytes. These findings suggest that ELOVL6 may be used as a valuable biomarker for the early diagnosis of CAC and may hold promise as a target for future therapies.

Citing Articles

Distinct Impact of Doxorubicin on Skeletal Muscle and Fat Metabolism in Mice: Without Dexrazoxane Effect.

Van Asbroeck B, Kruger D, Van den Bogaert S, Dombrecht D, Bosman M, Van Craenenbroeck E Int J Mol Sci. 2025; 26(3).

PMID: 39940943 PMC: 11818201. DOI: 10.3390/ijms26031177.

The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway.

Mahmud M, Siddique A, Tajmim A, King J, El Sayed K Molecules. 2025; 30(1.

PMID: 39795195 PMC: 11721798. DOI: 10.3390/molecules30010139.

The Effect of Mulberry Silage Supplementation on the Carcass Fatness and Long-Chain Fatty Acid Composition of Growing Lambs Compared with Traditional Corn Silage.

Zhao X, Zheng K, Wu J, Lv Z, Huang X, Jiang Y Foods. 2024; 13(17).

PMID: 39272504 PMC: 11395012. DOI: 10.3390/foods13172739.

References

Oliver E, McGillicuddy F, Harford K, Reynolds C, Phillips C, Ferguson J . Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. J Nutr Biochem. 2011; 23(9):1192-200. DOI: 10.1016/j.jnutbio.2011.06.014. View

Fearon K, Strasser F, Anker S, Bosaeus I, Bruera E, Fainsinger R . Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5):489-95. DOI: 10.1016/S1470-2045(10)70218-7. View

Nishihira J, Ishibashi T, Sakai M, Nishi S, Kondo H, Makita A . Identification of the fatty acid binding site on glutathione S-transferase P. Biochem Biophys Res Commun. 1992; 189(1):197-205. DOI: 10.1016/0006-291x(92)91544-z. View

Shin S, Ajuwon K . Effects of Diets Differing in Composition of 18-C Fatty Acids on Adipose Tissue Thermogenic Gene Expression in Mice Fed High-Fat Diets. Nutrients. 2018; 10(2). PMC: 5852832. DOI: 10.3390/nu10020256. View

Sun D, Ding Z, Shen L, Yang F, Han J, Wu G . miR-410-3P inhibits adipocyte differentiation by targeting IRS-1 in cancer-associated cachexia patients. Lipids Health Dis. 2021; 20(1):115. PMC: 8465700. DOI: 10.1186/s12944-021-01530-9. View

Jakobsson A, Westerberg R, Jacobsson A . Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res. 2006; 45(3):237-49. DOI: 10.1016/j.plipres.2006.01.004. View

Kobayashi T, Fujimori K . Very long-chain-fatty acids enhance adipogenesis through coregulation of Elovl3 and PPARγ in 3T3-L1 cells. Am J Physiol Endocrinol Metab. 2012; 302(12):E1461-71. DOI: 10.1152/ajpendo.00623.2011. View

Ikeda M, Kanao Y, Yamanaka M, Sakuraba H, Mizutani Y, Igarashi Y . Characterization of four mammalian 3-hydroxyacyl-CoA dehydratases involved in very long-chain fatty acid synthesis. FEBS Lett. 2008; 582(16):2435-40. DOI: 10.1016/j.febslet.2008.06.007. View

White J, Puppa M, Gao S, Sato S, Welle S, Carson J . Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK. Am J Physiol Endocrinol Metab. 2013; 304(10):E1042-52. PMC: 3651620. DOI: 10.1152/ajpendo.00410.2012. View

10.

Argiles J, Lopez-Soriano F, Stemmler B, Busquets S . Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol. 2023; 20(4):250-264. DOI: 10.1038/s41571-023-00734-5. View

11.

Jin L, Huang J, Guo L, Zhang B, Li Q, Li H . promotes colorectal cancer liver metastasis by enhancing the growth of metastatic cancer cells via a fatty acids-dependent manner. J Gastrointest Oncol. 2024; 14(6):2448-2465. PMC: 10772677. DOI: 10.21037/jgo-23-895. View

12.

Worgall T, Sturley S, Seo T, Osborne T, Deckelbaum R . Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J Biol Chem. 1998; 273(40):25537-40. DOI: 10.1074/jbc.273.40.25537. View

13.

Sandberg M, Hassett C, Adman E, Meijer J, Omiecinski C . Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms. J Biol Chem. 2000; 275(37):28873-81. DOI: 10.1074/jbc.M001153200. View

14.

Moon Y, Shah N, Mohapatra S, Warrington J, Horton J . Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J Biol Chem. 2001; 276(48):45358-66. DOI: 10.1074/jbc.M108413200. View

15.

Shin S, Ajuwon K . Divergent Response of Murine and Porcine Adipocytes to Stimulation of Browning Genes by 18-Carbon Polyunsaturated Fatty Acids and Beta-Receptor Agonists. Lipids. 2018; 53(1):65-75. DOI: 10.1002/lipd.12010. View

16.

Shimano H . Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res. 2001; 40(6):439-52. DOI: 10.1016/s0163-7827(01)00010-8. View

17.

Yehuda S, Rabinovitz S . The Role of Essential Fatty Acids in Anorexia Nervosa and Obesity. Crit Rev Food Sci Nutr. 2015; 56(12):2021-35. DOI: 10.1080/10408398.2013.809690. View

18.

Tan C, Virtue S, Bidault G, Dale M, Hagen R, Griffin J . Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6. Cell Rep. 2015; 13(10):2039-47. PMC: 4688035. DOI: 10.1016/j.celrep.2015.11.004. View

19.

Daly L, Dolan R, Power D, Ni Bhuachalla E, Sim W, Fallon M . The relationship between the BMI-adjusted weight loss grading system and quality of life in patients with incurable cancer. J Cachexia Sarcopenia Muscle. 2019; 11(1):160-168. PMC: 7015235. DOI: 10.1002/jcsm.12499. View

20.

Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C . Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2014; 33(1):90-9. DOI: 10.1200/JCO.2014.56.1894. View